Voting Results from BioNTech’s Annual General Meeting 2022
MAINZ, GERMANY, June 1, 2022 (GLOBE NEWSWIRE) At the Annual General Meeting (AGM) of BioNTech SE (Nasdaq: BNTX, BioNTech or the Company) held today, June 1, 2022, shareholders voted to reappoint Helmut Jeggle as a member of the Supervisory Board with a majority of 96.44 per cent.
- MAINZ, GERMANY, June 1, 2022 (GLOBE NEWSWIRE) At the Annual General Meeting (AGM) of BioNTech SE (Nasdaq: BNTX, BioNTech or the Company) held today, June 1, 2022, shareholders voted to reappoint Helmut Jeggle as a member of the Supervisory Board with a majority of 96.44 per cent.
- In a meeting following the AGM, the Supervisory Board re-elected Helmut Jeggle as its Chairman.
- This corresponds to approximately 484.2million, based on the shares outstanding and entitled to dividends as of May 30, 2022, being the record date relevant for determination.
- This is in line with BioNTechs capital allocation strategy and the companys commitment to delivering shareholder value, said Helmut Jeggle, Chairman of the Supervisory Board of BioNTech.